T2 Biosystems, Inc.
TTOO · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $16,391 | $7,242 | $81,972 | $150,449 |
| - Cash | $15,689 | $10,329 | $22,245 | $16,793 |
| + Debt | $49,498 | $59,217 | $58,323 | $56,919 |
| Enterprise Value | $50,200 | $56,130 | $118,050 | $190,575 |
| Revenue | $7,193 | $22,305 | $28,058 | $18,130 |
| % Growth | -67.8% | -20.5% | 54.8% | – |
| Gross Profit | -$8,170 | $1,166 | $7,355 | -$3,150 |
| % Margin | -113.6% | 5.2% | 26.2% | -17.4% |
| EBITDA | -$43,875 | -$54,872 | -$41,127 | -$36,709 |
| % Margin | -610% | -246% | -146.6% | -202.5% |
| Net Income | -$50,077 | -$62,003 | -$49,241 | -$46,798 |
| % Margin | -696.2% | -278% | -175.5% | -258.1% |
| EPS Diluted | -19.19 | -1,222.14 | -1,549.82 | -1,928.54 |
| % Growth | 98.4% | 21.1% | 19.6% | – |
| Operating Cash Flow | -$48,136 | -$50,629 | -$38,874 | -$43,215 |
| Capital Expenditures | -$192 | -$339 | -$460 | -$804 |
| Free Cash Flow | -$48,328 | -$50,968 | -$39,334 | -$44,019 |